134 related articles for article (PubMed ID: 26031530)
1. [Effects of SDF-1/CXCR4 signal pathway blockade by AMD3100 on the adhesion of leukemia cells to osteoblast niche and the drug resistance of leukemia cells].
Shen Z; Zeng D; Zou Z; Zhu L; Ma Y; Zhang X; Zhang C; Li J; Kong P
Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):413-7. PubMed ID: 26031530
[TBL] [Abstract][Full Text] [Related]
2. AMD3100 and G-CSF disrupt the cross-talk between leukemia cells and the endosteal niche and enhance their sensitivity to chemotherapeutic drugs in biomimetic polystyrene scaffolds.
Shen ZH; Zeng DF; Kong PY; Ma YY; Zhang X
Blood Cells Mol Dis; 2016 Jul; 59():16-24. PubMed ID: 27282562
[TBL] [Abstract][Full Text] [Related]
3. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Mineur P; Le Roy C; Saint-Georges S; Varin-Blank N; Cymbalista F; Bron D; Lagneaux L
Haematologica; 2012 Apr; 97(4):608-15. PubMed ID: 22058221
[TBL] [Abstract][Full Text] [Related]
4. Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib.
Dillmann F; Veldwijk MR; Laufs S; Sperandio M; Calandra G; Wenz F; Zeller J; Fruehauf S
Leuk Lymphoma; 2009 Oct; 50(10):1676-86. PubMed ID: 19657955
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
[TBL] [Abstract][Full Text] [Related]
6. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
Sison EA; Magoon D; Li L; Annesley CE; Rau RE; Small D; Brown P
Oncotarget; 2014 Oct; 5(19):8947-58. PubMed ID: 25333254
[TBL] [Abstract][Full Text] [Related]
7. [Role of CXCR4/STAT3 in mesenchymal stromal cell-mediated drug resistance of acute leukemia cells].
Tang Y; Guo Q; Zhi Y; Jin X; Xia B; Guo S; Tian C; Zhang Y
Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):119-23. PubMed ID: 27014981
[TBL] [Abstract][Full Text] [Related]
8. Osteoblasts protect AML cells from SDF-1-induced apoptosis.
Kremer KN; Dudakovic A; McGee-Lawrence ME; Philips RL; Hess AD; Smith BD; van Wijnen AJ; Karp JE; Kaufmann SH; Westendorf JJ; Hedin KE
J Cell Biochem; 2014 Jun; 115(6):1128-37. PubMed ID: 24851270
[TBL] [Abstract][Full Text] [Related]
9. AMD3100 and SDF‑1 regulate cellular functions of endothelial progenitor cells and accelerate endothelial regeneration in a rat carotid artery injury model.
Jiang C; Li R; Ma X; Hu H; Guo J; Zhao J
Mol Med Rep; 2020 Oct; 22(4):3201-3212. PubMed ID: 32945467
[TBL] [Abstract][Full Text] [Related]
10. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.
Zeng Y; Li B; Liang Y; Reeves PM; Qu X; Ran C; Liu Q; Callahan MV; Sluder AE; Gelfand JA; Chen H; Poznansky MC
FASEB J; 2019 May; 33(5):6596-6608. PubMed ID: 30802149
[TBL] [Abstract][Full Text] [Related]
11. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer.
Xue J; Li R; Gao D; Chen F; Xie H
Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392
[TBL] [Abstract][Full Text] [Related]
12. [Electroacupuncture combined with bone marrow mesenchymal stem cell transplantation promotes repair of thin endometrium by regulating SDF-1/CXCR4 signaling].
Hao SN; Xia LJ; Xi J; Liu JY; Zhu Q; Cheng J; Shen J; Xia YB
Zhen Ci Yan Jiu; 2023 Sep; 48(9):870-80. PubMed ID: 37730257
[TBL] [Abstract][Full Text] [Related]
13. [Icaritin promotes maturation and mineralization of mouse osteoblast MC3T3-E1 cells through CXCR4/SDF-1 signal pathway].
Wei Z; Shi W; Chen K; Zhou J; Wang M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(6):571-577. PubMed ID: 29658658
[TBL] [Abstract][Full Text] [Related]
14. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
15. The study of targeted blocking SDF-1/CXCR4 signaling pathway with three antagonists on MMPs, type II collagen, and aggrecan levels in articular cartilage of guinea pigs.
Wang G; Li Y; Meng X; Yang X; Xiang Y
J Orthop Surg Res; 2020 May; 15(1):195. PubMed ID: 32471458
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Drug Effect on Leukemia Cells Through Single Cell Assay With Optical Tweezers and Dielectrophoresis.
Hou J; Luo T; Ng KL; Leung AY; Liang R; Sun D
IEEE Trans Nanobioscience; 2016 Dec; 15(8):820-827. PubMed ID: 27775528
[TBL] [Abstract][Full Text] [Related]
17. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
[TBL] [Abstract][Full Text] [Related]
18. Effect of SDF-1/Cxcr4 Signaling Antagonist AMD3100 on Bone Mineralization in Distraction Osteogenesis.
Xu J; Chen Y; Liu Y; Zhang J; Kang Q; Ho K; Chai Y; Li G
Calcif Tissue Int; 2017 Jun; 100(6):641-652. PubMed ID: 28303319
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.
Mayr C; Neureiter D; Pichler M; Berr F; Wagner A; Kiesslich T; Namberger K
Mol Med Rep; 2015 Aug; 12(2):2247-52. PubMed ID: 25846744
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor inhibits CXCR4/SDF-1α signaling and overcomes stromal-mediated drug resistance in the HL-60 cell line.
Sheng X; Zhong H; Wan H; Zhong J; Chen F
Exp Ther Med; 2016 Jul; 12(1):396-404. PubMed ID: 27347068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
